Contingency management reduces drug-related human immunodeficiency virus risk behaviors in cocaine-abusing methadone patients

Addiction

Volumn 103, Issue 7, 2008, Pages 1187-1197

  Hanson, Tressa ^a   Alessi, Sheila M ^a   Petry, Nancy M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cocaine dependence; Contingency management; HIV risk behaviors; Methadone maintenance

Indexed keywords

METHADONE;

ADULT; ARTICLE; BEHAVIOR; BEHAVIOR THERAPY; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTINGENCY MANAGEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG INDUCED DISEASE; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OUTPATIENT DEPARTMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL ORIENTATION; STATISTICAL PARAMETERS; TREATMENT DURATION;

ADULT; ANALGESICS, OPIOID; BEHAVIOR THERAPY; FEMALE; HIV INFECTIONS; HUMANS; MALE; METHADONE; NEEDLE SHARING; OPIOID-RELATED DISORDERS; RISK-TAKING; SEXUAL BEHAVIOR; TREATMENT OUTCOME;

EID: 45349108145     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02216.x     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention 2007 Available at: http://www.cdc.gov/hiv/topics/ surveillance/resources/reports (accessed 20 June 2007).
2. Foster K., Nemoto T., Brown L. S., Battjes R. J. Needle sharing behaviors associated with HIV among intravenous drug users (IDUs): a two-year study. NIDA Res Monogr 1990 105 : 475 6.
3. Marmor M., Des Jarlais D. C., Cohen H., Friedman S. R., Beatrice S. T., Dubin N. et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987 1 : 39 44.
4. Des Jarlais D. C., Arasteh K., Perlis T., Hagan H., Abdul-Quader A., Heckathorn D. D. et al. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007 21 : 231 5.
5. Strathdee S. A., Sherman S. G. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health 2003 80 : 7 14.
6. Metzger D. S., Navaline H., Woody G. E. Drug abuse treatment as AIDS prevention. Public Health Rep 1998 113 : 97 106.
7. Hartel D. M., Schoenbaum E. E. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep 1998 113 : 107 15.
8. Ball J. C., Lange W. R., Myers C. P., Friedman S. R. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988 29 : 214 26.
9. Caplehorn J. R., Ross M. W. Methadone maintenance and the likelihood of risky needle-sharing. Int J Addict 1995 30 : 685 98.
10. Gossop M., Marsden J., Stewart D., Treacy S. Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study. AIDS Care 2002 14 : 77 93.
11. Lollis C. M., Strothers H. S., Chitwood D., McGhee M. Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior? J Behav Med 2000 23 : 545 57.
12. Dobler-Mikola A., Hattenschwiler J., Meili D., Beck T., Boni E., Modestin J. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J Subst Abuse Treat 2005 29 : 259 65.
13. Sees K. L., Delucchi K. L., Masson C., Rosen A., Clark H. W., Robillard H. et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA 2000 283 : 1303 10.
14. Bux D. A., Lamb R. J., Iguchi M. Y. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend 1995 37 : 29 35.
15. Camacho L. M., Bartholomew N. G., Joe G. W., Cloud M. A., Simpson D. D. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug Alcohol Depend 1996 41 : 1 7.
16. Sorensen J. L., Copeland A. L. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend 2000 59 : 17 31.
17. Magura S., Nwakeze P. C., Demsky S. Y. Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction 1998 93 : 51 60.
18. Higgins S. T., Budney A. J., Bickel W. K., Foerg F. E., Donham R., Badger G. J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994 51 : 568 76.
19. Petry N. M., Martin B., Cooney J. L., Kranzler H. R. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000 68 : 250 7.
20. Peirce J. M., Petry N. M., Stitzer M. L., Blaine J., Kellogg S., Satterfield F. et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network Study. Arch Gen Psychiatry 2006 63 : 201 8.
21. Silverman K., Robles E., Mudric T., Bigelow G. E., Stitzer M. L. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J Consult Clin Psychol 2004 72 : 839 54.
22. Lussier J. P., Heil S. H., Mongeon J. A., Badger G. J., Higgins S. T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006 101 : 192 203.
23. Prendergast M., Podus D., Finney J., Greenwell L., Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006 101 : 1546 60.
24. Petry N. M., Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol 2002 70 : 398 405.
25. Petry N. M., Martin B., Simcic F. Jr. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic. J Consult Clin Psychol 2005 73 : 354 9.
26. Petry N. M., Alessi S. M., Hanson T., Sierra S. Randomized trial of contingent prizes versus vouchers in cocaine using methadone patients. J Consult Clin Psychol 2007 75 : 983 91.
27. Higgins S. T., Badger G. J., Budney A. J. Initial abstinence and success in achieving longer-term cocaine abstinence. Exp Clin Psychopharmacol 2000 8 : 377 86.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC : Author 1994.
29. Folstein M. F., Folstein S. E., McHugh P. R. Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975 12 : 189 98.
30. Petry N. M., Kolodner K. B., Li R., Peirce J. M., Roll J. M., Stitzer M. L. et al. Prize-based contingency management does not increase gambling. Drug Alcohol Depend 2006 83 : 269 73.
31. First M. B., Spitzer R. L., Gibbon M., Williams J. B. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version. Washington, DC : American Psychiatric Press, Inc 1996.
32. Darke S., Hall W., Heather N., Ward J., Wodak A. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS 1991 5 : 181 5.
33. Petry N. M. Reliability of drug users' self-reported HIV risk behaviors using a brief, 11-item scale. Subst Use Misuse 2001 36 : 1731 47.
34. Stout R. L., Wirtz P. W., Carbonari J. P., Del Boca F. K. Ensuing balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol 1994 12 : 70 5.
35. Aiken M. A program for balancing the allocation of subjects in a clinical trial. Comput Biomed Res 1982 15 : 519 24.
36. Morgenstern J., Longabaugh R. Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction 2000 95 : 1475 90.
37. Griffith J. D., Rowan-Szal G. A., Roark R. R., Simpson D. D. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend 2000 58 : 55 66.
38. Preston K. L., Umbricht A., Epstein D. H. Abstinence reinforcement maintenance contingency and one-year follow-up. Drug Alcohol Depend 2002 67 : 125 37.
39. Silverman K., Higgins S. T., Brooner R. K., Montoya I. D., Cone E. J., Schuster C.R. et al. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry 1996 53 : 409 15.
40. Petry N. M., Peirce J., Stitzer M. L., Blaine J., Roll J. M., Cohen A. et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a National Drug Abuse Treatment Clinical Trials Network Study. Arch Gen Psychiatry 2005 62 : 1148 56.
41. Petry N. M., Alessi S. M., Carroll K. M., Hanson T., MacKinnon S., Rounsaville R. et al. Contingency management treatments: reinforcing abstinence versus adherence with goal-related activities. J Consul Clin Psychol 2006 74 : 592 601.
42. Schroeder J. R., Epstein D. H., Umbricht A., Preston K. L. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence. Addict Behav 2006 31 : 868 79.
43. Shoptaw S., Reback C. J., Peck J. A., Yang X., Rotheram-Fuller E., Larkins S. et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend 2005 78 : 125 34.
44. Marks G., Crepaz N., Senterfitt J. W., Janssen R. S. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005 39 : 446 53.
45. Robles R. R., Matos T. D., Colon H. M., Marrero C. A., Reyes J. C. Effects of HIV testing and counseling on reducing HIV risk behavior among two ethnic groups. Drugs Soc 1996 9 : 173 84.
46. Wilson T. E., Massad L. S., Riester K. A., Barkan S., Richardson J., Young M. et al. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: results for the Women's Interagency HIV Study. AIDS 1999 13 : 591 8.